Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-13-061833
Filing Date
2013-08-09
Accepted
2013-08-08 17:57:45
Documents
10
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a13-13456_110q.htm 10-Q 1451314
2 EX-31.1 a13-13456_1ex31d1.htm EX-31.1 11372
3 EX-31.2 a13-13456_1ex31d2.htm EX-31.2 11416
4 EX-32.1 a13-13456_1ex32d1.htm EX-32.1 9293
  Complete submission text file 0001104659-13-061833.txt   13761709

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT onxx-20130630.xml EX-101.INS 1299210
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT onxx-20130630.xsd EX-101.SCH 105027
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT onxx-20130630_cal.xml EX-101.CAL 74531
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT onxx-20130630_def.xml EX-101.DEF 546285
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT onxx-20130630_lab.xml EX-101.LAB 1711954
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT onxx-20130630_pre.xml EX-101.PRE 893720
Mailing Address 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080
Business Address 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080 650-266-0000
ONYX PHARMACEUTICALS INC (Filer) CIK: 0001012140 (see all company filings)

EIN.: 943154463 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-28298 | Film No.: 131023409
SIC: 2836 Biological Products, (No Diagnostic Substances)